Blueberry Therapeutics
Aug 16, 2018
The Business Cocktail(Therapeutics)
Blueberry Therapeutics reels in USD 12.7 Million in series B funding for fungal infections. U.K.based, Blueberry Therapeutics successfully bagged a funding of USD 12.7 million in series B funding. The funding will help the company to advance its nanomedicine candidate, BB2603 for two fungal infections namely- Ath...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
